Author:
Kohorst Mira A.,Khan Shakila P.
Reference93 articles.
1. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma;Cheung;J Clin Oncol,1991
2. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children’s Cancer Group results;Matthay;Eur J Cancer,1995
3. Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group;Dini;Bone Marrow Transplant,1989
4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group;Matthay;N Engl J Med,1999
5. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma;Grupp;J Clin Oncol,2000